| Literature DB >> 26199709 |
Farkhondeh Sharif1, Shekufe Zarei1, Ali Alavi Shooshtari2, Mehrdad Vossoughi3.
Abstract
BACKGROUND: Attention deficit hyperactivity disorder is one of the most common psychiatric disorders in children.Entities:
Keywords: Attention Deficit Disorder with Hyperactivity; Mental Health
Year: 2015 PMID: 26199709 PMCID: PMC4505991 DOI: 10.5812/ijp.25(3)2015.474
Source DB: PubMed Journal: Iran J Pediatr ISSN: 2008-2142 Impact factor: 0.364
Figure 1.The Mean Stress Scores in the Intervention, Placebo, and Control Groups
Figure 2.The Mean Mental Health Scores in the Intervention, Placebo, and Control Groups
The Mean Depression-Anxiety-Stress and Mental Health Scores at Baseline, Immediately After, and one Month After the Intervention in Separate Groups
| Experimental | Times[ | P Value |
|---|---|---|
|
| ||
| 0-1 | 0.006 | |
| 0-2 | 0.001 | |
| 2-1 | 0.089 | |
|
| ||
| 0-1 | 0.999 | |
| 0-2 | 0.077 | |
| 2-1 | 0.004 | |
|
| ||
| 0-1 | 0.999 | |
| 0-2 | 0.070 | |
| 2-1 | 0.210 | |
|
| ||
| 0-1 | < 0.001 | |
| 0-2 | < 0.001 | |
| 2-1 | 0.999 |
aTime 0, baseline; Time 1, immediately after the intervention; and Time 2, one month after the intervention.
Changes in the Scores of Mental Health and Depression-Anxiety-Stress at Baseline, Immediately After the Intervention, and One Month After the Intervention
| Variables | Time[ | Intervention group | Placebo group | Control group | P Value | P Value (post-hoc test) |
|---|---|---|---|---|---|---|
| Stress | ||||||
| 0 | 15.23 ± 3.36 | 13.88 ± 3.21 | 13.66 ± 3.90 | 0.181 | Intervention control: 0.057; Placebo control: 0.067 | |
| 1 | 12.29 ± 4.32 | 12.33 ± 3.75 | 14.77 ± 3.69 | 0.033 | Intervention control: 0.017; Placebo control: 0.040 | |
| 2 | 11.34 ± 4.39 | 11.69 ± 3.51 | 14.33 ± 3.66 | 0.012 | ||
|
| ||||||
| 0 | 10.22 ± 4.97 | 10.23 ± 4.72 | 11.11 ± 4.22 | 0.700 | Placebo control: 0.014 | |
| 1 | 10.33 ± 4.72 | 9.11 ± 3.53 | 12.25 ± 3.98 | 0.018 | Intervention control: 0.001; Placebo control: 0.006 | |
| 2 | 8.29 ± 4.47 | 8.88 ± 2.84 | 12.35 ± 3.88 | 0.001 | ||
|
| ||||||
| 0 | 8.14 ± 3.69 | 8.74 ± 3.98 | 8.88 ± 5.56 | 0.815 | Intervention control: < 0.001; Placebo control: 0.001 | |
| 1 | 7.74 ± 4.51 | 7.96 ± 4.44 | 10.37 ± 5.00 | 0.078 | ||
| 2 | 6.59 ± 4.27 | 7.03 ± 4.15 | 11.29 ± 4.25 | < 0.001 | ||
|
| ||||||
| 0 | 34.42 ± 13.22 | 34.08 ± 15.71 | 37.66 ± 14.64 | 0.484 | Intervention placebo: 0.047; Intervention control: 0.001 | |
| 1 | 20.50 ± 10.56 | 30.48 ± 12.94 | 33.70 ± 12.60 | 0.001 | Intervention placebo: 0.012;Intervention control: < 0.001 | |
| 2 | 21.73 ± 9.43 | 31.32 ± 13.59 | 37.03 ± 11.73 | < 0.001 |
aTime 0, baseline; Time 1, immediately after the intervention; and Time 2, one month after the intervention.